
News|Articles|February 1, 2002
Dutasteride (Dutasteride soft-gelatin capsules), GlaxoSmithKline
NME: 5-alpha reductase inhibitor for treatmentof benign prostatic hyperplasia
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Daraxonrasib trial exceeds expectations after decades of disappointment in pancreatic cancer drug development
2
340B reform and drug shortages are among hospital pharmacy concerns, survey finds
3
Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2025
4
Alyana Samai, M.P.H. | 2026 MHE Emerging Leaders in Healthcare
5


























